SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 285.15 |
| Enterprise Value ($M) | 295.33 |
| Book Value ($M) | 140.48 |
| Book Value / Share | 2.27 |
| Price / Book | 2.03 |
| NCAV ($M) | 135.88 |
| NCAV / Share | 2.20 |
| Price / NCAV | 2.10 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.38 |
| Return on Assets (ROA) | -0.50 |
| Return on Equity (ROE) | -0.69 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 13.36 |
| Current Ratio | 13.36 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 196.25 |
| Assets | 200.85 |
| Liabilities | 60.37 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -75.64 |
| Net Income | -71.17 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -70.67 |
| Cash from Investing | -53.65 |
| Cash from Financing | 125.97 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Sofinnova Venture Partners X, L.P. | 6.90 | 111.03 | |
| 13G | Eventide Asset Management, Llc | 5.15 | ||
| 13G | Samlyn Capital, Llc | 5.50 | ||
| 13G/A | New Enterprise Associates 15, L.P. | |||
| 13G/A | Venrock Healthcare Capital Partners II, L.P. | 0.00 | -100.00 | |
| 13G/A | Rock Springs Capital Management LP | 5.96 | 19.29 | |
| 13G/A | Deep Track Capital, LP | 0.00 | -100.00 | |
| 13G/A | Baker Bros. Advisors Lp | 0.00 | -100.00 | |
| 13D/A | Pivotal bioVenture Partners Fund I, L.P. | 7.20 | 0.00 | |
| 13G/A | Adage Capital Partners Gp, L.l.c. | 8.97 | 78.62 | |
| 13G/A | Sphera Funds Management Ltd. | 2.53 | -25.44 | |
| 13G/A | Millennium Management Llc | 1.50 | -60.25 | |
| 13D/A | Longitude Capital Partners III, LLC | 9.90 | 39.93 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 74,460 | 485,857 | 15.33 | |
| 68,866 | 461,981 | 14.91 | |
| 92,889 | 163,338 | 56.87 | |
| 98,836 | 174,817 | 56.54 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| INNV – InnovAge Holding Corp. | INSM – Insmed Incorporated |
| INVA – Innoviva, Inc. | IOBT – IO Biotech, Inc. |
| IONS – Ionis Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io